TENET HEALTHCARE CORP
THCAPI behind this page
THC FY 2025 request
Playground key active
/api/financials?ticker=THC&year=2025&quarter=4&full_year_mode=true
Pick an endpoint and run the request.
Income Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Revenue | 21,310 | 20,675 | +3.1% |
Show Product Lines breakouts |
|||
| Health Care Patient Service · Ambulatory Care | 4,956 | 4,356 | +13.8% |
| Health Care, Patient Service - Medicaid [Member] · Hospital Operations | 1,524 | 1,439 | +5.9% |
| Indemnity and other · Hospital Operations | 551 | 522 | +5.6% |
| Managed care · Hospital Operations | 9,696 | 9,809 | -1.2% |
| Medicare [Member] · Hospital Operations | 2,119 | 2,132 | -0.6% |
| Other Revenues · Hospital Operations | 2,196 | 2,175 | +1.0% |
| Revenue from other sources · Ambulatory Care | 216 | 178 | +21.3% |
| Total · Hospital Operations | 13,942 | 13,966 | -0.2% |
| Uninsured · Hospital Operations | 52 | 64 | -18.8% |
Show Business Segments breakouts |
|||
| Ambulatory Care | 5,172 | 4,534 | +14.1% |
| Ambulatory Care · Operating Segments | 5,172 | 4,534 | +14.1% |
| Hospital Operations · Operating Segments | 16,138 | 16,141 | -0.0% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 21,310 | 20,675 | +3.1% |
Show Restatement breakouts |
|||
| Restatement Adjustment | 23 | -4 | +675.0% |
Show Equity Method Investment Nonconsolidated Investee breakouts |
|||
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | 3,902 | 3,709 | +5.2% |
| Income Loss From Equity Method Investments | 264 | 260 | +1.5% |
Show Business Segments breakouts |
|||
| Ambulatory Care | 258 | 250 | +3.2% |
| Hospital Operations | 6 | 10 | -40.0% |
Show Schedule Of Equity Method Investment Equity Method Investee Name breakouts |
|||
| Texas Health Ventures Group, LLC | 141 | 130 | +8.5% |
| Labor And Related Expense | 8,705 | 8,801 | -1.1% |
Show Business Segments breakouts |
|||
| Ambulatory Care | 1,265 | 1,137 | +11.3% |
| Hospital Operations | 7,440 | 7,664 | -2.9% |
| Supplies Expense | 3,780 | 3,647 | +3.6% |
Show Business Segments breakouts |
|||
| Ambulatory Care | 1,375 | 1,187 | +15.8% |
| Hospital Operations | 2,405 | 2,460 | -2.2% |
| Other Cost And Expense Operating | 4,523 | 4,492 | +0.7% |
Show Business Segments breakouts |
|||
| Ambulatory Care | 764 | 650 | +17.5% |
| Hospital Operations | 3,759 | 3,842 | -2.2% |
| Depreciation & Amortization | 863 | 818 | +5.5% |
Show Business Segments breakouts |
|||
| Ambulatory Care | 152 | 134 | +13.4% |
| Hospital Operations | 711 | 684 | +3.9% |
| Restructuring Settlement Impairment Provisions And Acquisition Cost | 130 | 102 | +27.5% |
| Litigation Settlement Expense | 64 | 35 | +82.9% |
| Net Gains Losses On Sale Consolidation And Deconsolidation Of Facilities | 1 | -2,916 | +100.0% |
| Operating Income | 3,508 | 5,956 | -41.1% |
| Interest Expense | -821 | -826 | +0.6% |
| Other Non-Operating Income (Expense) | 117 | 126 | -7.1% |
| Gains Losses On Extinguishment Of Debt | -4 | -8 | +50.0% |
Show Long-Term Debt Type breakouts |
|||
| Senior Notes | -7 | -8 | +12.5% |
| Income Loss Including Portion Attributable To Noncontrolling Interest | 2,800 | 5,248 | -46.6% |
| Income Tax Expense (Benefit) | -433 | -1,184 | +63.4% |
| Net Income | 2,367 | 4,064 | -41.8% |
Show Equity Method Investment Nonconsolidated Investee breakouts |
|||
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | 1,021 | 978 | +4.4% |
| Net Income Loss Attributable To Noncontrolling Interest | 960 | 864 | +11.1% |
| Net Income Loss Available To Common Stockholders Basic | 1,407 | 3,200 | -56.0% |
| EPS (Basic) | 15.61 | 33.02 | -52.7% |
| EPS (Diluted) | 15.49 | 32.7 | -52.6% |
| Wtd Avg Shares (Basic) | 90,150 | 96,904 | -7.0% |
| Wtd Avg Shares (Diluted) | 90,833 | 97,881 | -7.2% |
| Income Before Taxes | 2,800 | 5,248 | -46.6% |
| Comprehensive Income | 1,406 | 3,201 | -56.1% |
Balance Sheet
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 2,883 | 3,019 | -4.5% |
Show Legal Entity breakouts |
|||
| Captive Insurance Subsidiaries | 108 | 110 | -1.8% |
| Accounts Receivable | 2,565 | 2,536 | +1.1% |
Show Accounts Notes Loans And Financing Receivable By Receivable Type breakouts |
|||
| California's Provider Fee Program | 493 | 334 | +47.6% |
| Inventory | 348 | 346 | +0.6% |
| Assets Of Disposal Group Including Discontinued Operation Current | 62 | 21 | +195.2% |
| Other Assets Current | 1,991 | 1,760 | +13.1% |
| Total Current Assets | 7,849 | 7,682 | +2.2% |
Show Equity Method Investment Nonconsolidated Investee breakouts |
|||
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | 1,202 | 1,255 | -4.2% |
| Non-Current Assets | |||
| Deferred Tax Assets | 84 | 80 | +5.0% |
| Goodwill | 11,198 | 10,691 | +4.7% |
Show Business Segments breakouts |
|||
| Ambulatory Care | 8,501 | 7,994 | +6.3% |
| Hospital Operations | 2,697 | 2,697 | 0.0% |
Show Business Acquisition breakouts |
|||
| Series Of Individually Immaterial Business Acquisitions | 544 | 951 | -42.8% |
| Total Assets | 29,677 | 28,936 | +2.6% |
Show Business Segments breakouts |
|||
| Ambulatory Care | 13,091 | 12,214 | +7.2% |
| Hospital Operations | 16,586 | 16,722 | -0.8% |
| Operating Lease Right-of-Use Assets | 1,134 | 1,037 | +9.4% |
| Intangible Assets | 466 | 518 | -10.0% |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Computer Software Intangible Asset | 345 | 394 | -12.4% |
| Contract Based Intangible Assets | 93 | 106 | -12.3% |
| Other Intangible Assets | 28 | 18 | +55.6% |
| Marketable Securities (Non-Current) | 59 | 50 | +18.0% |
| Long Term Investments | 1,442 | 1,532 | -5.9% |
| Other Assets | |||
| Long Term Investments And Receivables Net | 2,883 | 3,037 | -5.1% |
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | 6,315 | 6,049 | +4.4% |
| Intangible Assets Net Excluding Goodwill | 1,348 | 1,397 | -3.5% |
| Current Liabilities | |||
| Long Term Debt And Capital Lease Obligations Current | 79 | 92 | -14.1% |
| Accounts Payable | 1,360 | 1,294 | +5.1% |
Show Accounts Notes Loans And Financing Receivable By Receivable Type breakouts |
|||
| California's Provider Fee Program | 232 | 126 | +84.1% |
| Employee Related Liabilities Current | 858 | 899 | -4.6% |
| Self Insurance Reserve Current | 276 | 238 | +16.0% |
| Interest Payable Current | 81 | 149 | -45.6% |
| Other Liabilities Current | 1,809 | 1,607 | +12.6% |
| Total Current Liabilities | 4,463 | 4,310 | +3.5% |
Show Equity Method Investment Nonconsolidated Investee breakouts |
|||
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | 434 | 435 | -0.2% |
| Deferred Revenue (Current) (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Hospital Operations | 88 | 80 | +10.0% |
| Non-Current Liabilities | |||
| Self Insurance Reserve Noncurrent | 951 | 900 | +5.7% |
| Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent | 245 | 298 | -17.8% |
| Deferred Tax Liabilities | 240 | 227 | +5.7% |
| Other Non-Current Liabilities | 1,713 | 1,573 | +8.9% |
| Total Liabilities | 20,704 | 20,389 | +1.5% |
| Operating Lease Liabilities | 1,043 | 950 | +9.8% |
| Contract With Customer Liability Noncurrent (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Hospital Operations | 13 | 13 | 0.0% |
| Other Liabilities | |||
| Long Term Debt And Capital Lease Obligations | 13,092 | 13,081 | +0.1% |
| Redeemable Noncontrolling Interest Equity Carrying Amount | 2,956 | 2,727 | +8.4% |
| Stockholders' Equity | |||
| Common Stock | 8 | 8 | 0.0% |
| Additional Paid-In Capital | 4,914 | 4,873 | +0.8% |
| Accumulated Other Comprehensive Income | -181 | -180 | -0.6% |
| Retained Earnings | 4,415 | 3,008 | +46.8% |
| Treasury Stock Common Value | -4,936 | -3,538 | -39.5% |
| Total Stockholders' Equity | 4,220 | 4,171 | +1.2% |
| Minority Interest | 1,797 | 1,649 | +9.0% |
Show Equity Method Investment Nonconsolidated Investee breakouts |
|||
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | 728 | 699 | +4.1% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 6,017 | 5,820 | +3.4% |
Show Business Segments breakouts |
|||
| Ambulatory Care · Noncontrolling Interest | 1,586 | 1,444 | +9.8% |
| Hospital Operations · Noncontrolling Interest | 211 | 205 | +2.9% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment Including Portion Attributable To Noncontrolling Interest | -183 | -181 | -1.1% |
| Accumulated Foreign Currency Adjustment Including Portion Attributable To Noncontrolling Interest | 1 | 1 | 0.0% |
| Accumulated Net Investment Gain Loss Including Portion Attributable To Noncontrolling Interest | 1 | — | — |
| Accumulated Other Comprehensive Income | -181 | -180 | -0.6% |
| Additional Paid In Capital | 4,914 | 4,873 | +0.8% |
| Aoci Including Portion Attributable To Noncontrolling Interest | -181 | -180 | -0.6% |
| Common Stock | 8 | 8 | 0.0% |
| Noncontrolling Interest | 1,797 | 1,649 | +9.0% |
| Retained Earnings | 4,415 | 3,008 | +46.8% |
| Treasury Stock Common | -4,936 | -3,538 | -39.5% |
| Total Liabilities & Equity | 29,677 | 28,936 | +2.6% |
Cash Flow Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Deferred Income Taxes | 9 | -103 | +108.7% |
| Stock-Based Compensation | 104 | 67 | +55.2% |
| Gain Loss Related To Litigation Settlement | 64 | 35 | +82.9% |
Show Litigation Status breakouts |
|||
| Pending Litigation | 64 | 35 | +82.9% |
| Net Gain Loss On Sale Consolidation And Deconsolidation Of Facilities | 1 | -2,916 | +100.0% |
| Income Loss From Equity Method Investments Net Of Dividends Or Distributions | -34 | -29 | -17.2% |
| Amortization Of Financing Costs And Discounts | 23 | 26 | -11.5% |
| Gain Loss On Disposition Of Assets1 | -4 | -4 | 0.0% |
| Other Non-Cash Items | -6 | -4 | -50.0% |
| Change in Accounts Receivable | 20 | 245 | -91.8% |
| Increase Decrease In Inventories And Other Assets Current | -73 | -86 | +15.1% |
| Increase Decrease In Income Taxes Receivable | -25 | 16 | -256.2% |
| Increase Decrease In Accounts Payable And Accrued Liabilities | 209 | -30 | +796.7% |
| Increase Decrease In Other Operating Liabilities | 9 | -9 | +200.0% |
| Net Cash from Operations | 3,540 | 2,047 | +72.9% |
| Change in Deferred Revenue (FY) | — | — | — |
Show Business Segments breakouts |
|||
| Hospital Operations · Short Term Contract With Customer | 8 | 21 | -61.9% |
| Investing Activities | |||
| Capital Expenditures | -1,010 | -931 | -8.5% |
| Payments To Acquire Businesses Net Of Cash Acquired | -308 | -571 | +46.1% |
Show Business Acquisition breakouts |
|||
| Series Of Individually Immaterial Business Acquisitions | -301 | -561 | +46.3% |
| Proceeds From Divestiture Of Businesses | 38 | 4,981 | -99.2% |
| Proceeds From Sale Of Marketable Securities Long Term Investments And Other Assets | 93 | 63 | +47.6% |
| Payments To Acquire Investments | -90 | -94 | +4.3% |
| Other Investing Activities | 2 | -19 | +110.5% |
| Net Cash from Investing | -1,275 | 3,429 | -137.2% |
| Financing Activities | |||
| Debt Repayments | -2,372 | -2,243 | -5.8% |
| Proceeds From Issuance Of Debt | 2,276 | 23 | +9795.7% |
| Share Repurchases | -1,386 | -672 | -106.2% |
| Debt Issuance Costs | -32 | — | — |
| Payments Of Dividends Minority Interest | -809 | -681 | -18.8% |
| Proceeds From Sale Of Interest In Corporate Unit | 42 | 23 | +82.6% |
| Payments To Minority Shareholders | -92 | -200 | +54.0% |
| Repayments Of Advances From Managed Care Payers | -32 | -310 | +89.7% |
| Tax Withholding for Share Compensation | -51 | -25 | -104.0% |
| Proceeds From Payments For Other Financing Activities | 55 | 58 | -5.2% |
| Net Cash from Financing | -2,401 | -3,685 | +34.8% |
| Supplemental | |||
| Interest Paid | -865 | -851 | -1.6% |
| Income Taxes Paid | -450 | -1,271 | +64.6% |
| Unpaid Capital Expenditures | 111 | 127 | -12.6% |
| Other Cash Flow | |||
| Payments For Restructuring And Litigation Costs | -121 | -153 | +20.9% |
| Net Change in Cash | -136 | 1,791 | -107.6% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 2,883 | 3,019 | -4.5% |
Values in millions USD. Source: SEC EDGAR 10-K filing.